TherapeuticsMD
TXMD
#10160
Rank
$20.13 M
Marketcap
$1.74
Share price
8.07%
Change (1 day)
41.46%
Change (1 year)

Revenue for TherapeuticsMD (TXMD)

Revenue in 2025 (TTM): $2.55 Million USD

According to TherapeuticsMD's latest financial reports the company's current revenue (TTM ) is $2.55 Million USD. In 2024 the company made a revenue of $1.76 Million USD an increase over the revenue in the year 2023 that were of $1.3 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TherapeuticsMD from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $2.55 M45.32%
2024 $1.76 M35.25%
2023 $1.3 M-48.92%
2022 $2.54 M-97.07%
2021 $86.95 M34.04%
2020 $64.87 M30.67%
2019 $49.64 M208.38%
2018 $16.09 M-4.04%
2017 $16.77 M-13.32%
2016 $19.35 M-3.9%
2015 $20.14 M34.05%
2014 $15.02 M71.23%
2013 $8.77 M129.85%
2012 $3.81 M5.48%
2011 $3.61 M17676.4%
2010 $0.02 M92.67%
2009 $0.01 M
2006 $1 M8.2%
2005 $0.92 M48.94%
2004 $0.62 M42.55%
2003 $0.43 M52.68%
2002 $0.28 M-13.82%
2001 $0.33 M-9.63%
2000 $0.36 M72.03%
1999 $0.21 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Agile Therapeutics
AGRX
$21.56 M 742.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
$0.31 B 12,040.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$62.78 B 2,453,436.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$59.64 B 2,330,654.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
$2.34 B 91,726.65%๐Ÿ‡ฌ๐Ÿ‡ง UK